Skip to main content

Table 1 Results of two-sample Mendelian randomization analyses on glucose-lowering drug targets and risks of gastrointestinal cancer

From: Association of glucose-lowering drug target and risk of gastrointestinal cancer: a mendelian randomization study

Gene

Cancer

Discovery Cohort

Validation Cohort

Combined

OR (95% CI)

P-value

OR (95% CI)

P-value

OR (95% CI)

P-value

ABCC8 + KCNJ11

Anal Carcinoma

2.749 × 10− 4 (1.18 × 10− 6, 0.064)

0.003

4.370 × 10− 6 (1.700 × 10− 10, 0.112)

0.017

1.000 × 10− 4 (0.0001, 0.013)

0.0002

 

Cardia Cancer

4.217 (0.007, 2.46 × 103)

0.658

0.518 (0.091, 2.952)

0.459

0.600 (0.112, 3.211)

0.550

 

Gastric Cancer

0.107 (0.001, 22.430)

0.412

0.884 (0.364, 2.147)

0.786

0.835 (0.348, 2.005)

0.687

 

Hepatocellular Carcinoma

0.009 (1.01 × 10− 4, 0.852)

0.042

0.001 (8.782 × 10− 5, 0.026)

7.058 × 10− 6

0.003 (2.000 × 10− 4, 0.028)

< 0.0001

 

Intrahepatic Cholangiocarcinoma

440.752 (1.751, 1.11 × 105)

0.031

56.759 (6.941, 464.115)

1.651 × 10− 4

73.520 (10.312, 524.150)

< 0.0001

 

Pancreatic Cancer

8.440 (1.633, 43.635)

0.010

56.728 (4.720, 681.753)

0.001

15.058 (3.824, 59.295)

0.0001

 

Rectum Cancer

3.805 (0.871, 16.620)

0.076

0.280 (0.073, 1.068)

0.062

0.911 (0.338, 2.457)

0.855

DPP4

Anal Carcinoma

4.453 × 10− 6 (2.04 × 10− 8, 0.001)

7.325 × 10− 6

0.447 (0.020, 0.910)

0.005

0.123 (0.020, 0.745)

0.023

 

Cardia Cancer

0.152 (0.004, 6.255)

0.321

5.092 (0.669, 38.723)

0.402

2.275 (0.383, 13.501)

0.366

 

Gastric Cancer

0.192 (0.003, 13.660)

0.449

1.251 (0.430, 3.645)

0.681

1.120 (0.397, 3.160)

0.830

 

Hepatocellular Carcinoma

19.221 (1.47 × 10− 4, 2.51 × 106)

0.623

3.455 (0.312, 382.858)

0.389

3.988 (0.133, 120.054)

0.426

 

Intrahepatic Cholangiocarcinoma

7.993 × 103 (51.330, 1.25 × 106)

4.846 × 10− 4

3.991 (0.839, 18.977)

0.082

7.733 (1.743, 34.310)

0.007

 

Pancreatic Cancer

0.315 (0.074, 1.334)

0.117

0.455 (0.053, 3.904)

0.472

0.353 (0.106, 1.170)

0.089

 

Rectum Cancer

2.685 (0.110, 65.590)

0.545

8.268 (0.278, 246.197)

0.148

4.555 (0.445, 46.650)

0.202

ETFDH

Anal Carcinoma

0.004 (2.47 × 10− 14, 6.53 × 108)

0.675

0.684 (0.025, 190.226)

0.990

0.589 (0.007, 48.429)

0.814

 

Cardia Cancer

3.149 × 10− 4 (6.35 × 10− 11, 1.56 × 103)

0.305

1.228 (0.129, 11.711)

0.953

1.032 (0.111, 9.616)

0.978

 

Gastric Cancer

1.578 (3.17 × 10− 8, 7.86 × 107)

0.96

0.666 (0.022, 20.340)

0.816

0.687 (0.024, 19.720)

0.826

 

Hepatocellular Carcinoma

3.949 (1.34 × 10− 9, 1.16 × 1010)

0.902

4.262 (0.037, 485.767)

0.345

4.248 (0.042, 434.573)

0.540

 

Intrahepatic Cholangiocarcinoma

0.070 (5.75 × 10− 11, 8.57 × 107)

0.803

0.490 (0.000, 611.716)

0.845

0.401 (0.001, 341.417)

0.790

 

Pancreatic Cancer

8.505 (0.025, 2.95 × 103)

0.473

6.546 (0.142, 302.443)

0.132

7.082 (0.287, 174.724)

0.231

 

Rectum Cancer

3.248 (0.012, 8.59 × 102)

0.679

0.083 (0.001, 9.994)

0.309

0.394 (0.010, 14.895)

0.615

GLP1R

Anal Carcinoma

1.044 × 104 (9.548, 1.14 × 107)

0.010

9.431 (0.194, 458.377)

0.150

49.160 (1.648, 1.466 × 103)

0.025

 

Cardia Cancer

3.094 × 102 (3.695, 2.59 × 104)

0.011

17.191 (3.092, 95.583)

0.536

25.073 (5.064, 124.149)

< 0.0001

 

Gastric Cancer

19.724 (0.189, 2.06 × 103)

0.209

0.553 (0.293, 1.043)

0.067

1.526 (0.065, 35.899)

0.793

 

Hepatocellular Carcinoma

0.046 (5.91 × 10− 4, 3.645)

0.168

2.666 (0.205, 34.673)

0.454

0.942 (0.103, 8.597)

0.958

 

Intrahepatic Cholangiocarcinoma

63.028 (0.261, 1.52 × 104)

0.139

0.975 (0.187, 5.091)

0.976

1.379 (0.283, 6.714)

0.690

 

Pancreatic Cancer

1.085 (0.274, 4.292)

0.907

7.414 (0.732, 75.066)

0.090

1.792 (0.549, 5.846)

0.334

 

Rectum Cancer

4.290 (0.795, 23.160)

0.091

1.136 (0.302, 4.273)

0.851

1.886 (0.665, 5.346)

0.233

GPD2

Anal Carcinoma

2.365 × 103 (1.74 × 10− 10, 3.22 × 1016)

0.615

14.585 (0.004, 500.561)

0.380

17.511 (0.057, 5.406 × 103)

0.328

 

Cardia Cancer

0.509 (2.28 × 10− 7, 1.14 × 106)

0.928

4.010 (0.516, 313.133)

0.078

3.648 (0.160, 83.440)

0.418

 

Gastric Cancer

2.869 × 103 (1.32 × 10− 4, 6.25 × 1010)

0.356

1.267 (0.040, 40.233)

0.893

1.729 (0.058, 51.164)

0.752

 

Hepatocellular Carcinoma

2.161 (3.09 × 10− 7, 1.51 × 107)

0.924

0.009 (7.779 × 10− 8, 1.132 × 103)

0.434

0.065 (0.0001, 779.411)

0.568

 

Intrahepatic Cholangiocarcinoma

3.333 × 104 (6.74 × 10− 5, 1.65 × 1013)

0.308

0.002 (7.750 × 10− 8, 76.031)

0.254

0.078 (0.0001, 766.568)

0.586

 

Pancreatic Cancer

8.064 (0.024, 2.71 × 103)

0.482

12.495 (0.003, 4.623 × 104)

0.547

9.334 (0.081, 1.076 × 103)

0.357

 

Rectum Cancer

0.004 (1.83 × 10− 5, 0.728)

0.038

0.062 (0.003, 1.277)

0.086

0.031 (0.002, 0.428)

0.010

INSR

Anal Carcinoma

1.095 × 103 (0.001, 1.99 × 109)

0.341

0.381 (0.008, 173.995)

0.885

0.889 (0.008, 97.817)

0.961

 

Cardia Cancer

5.233 × 103 (0.032, 8.60 × 108)

0.162

9.896 (0.103, 94.798)

0.058

15.804 (0.594, 420.471)

0.099

 

Gastric Cancer

0.031 (3.35 × 10− 8, 2.96 × 104)

0.622

2.047 (0.139, 30.057)

0.601

1.756 (0.126, 24.528)

0.676

 

Hepatocellular Carcinoma

0.050 (4.49 × 10− 7, 5.49 × 103)

0.612

0.067 (2.086 × 10− 4, 21.519)

0.359

0.063 (4.000 × 10− 4, 11.094)

0.295

 

Intrahepatic Cholangiocarcinoma

0.001 (4.81 × 10− 10, 2.41 × 103)

0.360

0.036 (0.001, 1.513)

0.081

0.029 (0.001, 1.086)

0.056

 

Pancreatic Cancer

0.397 (0.007, 21.720)

0.651

11.007 (0.023, 5.234 × 103)

0.446

1.063 (0.037, 30.495)

0.972

 

Rectum Cancer

0.669 (0.014, 33.000)

0.840

0.428 (0.032, 5.811)

0.524

0.492 (0.056, 4.292)

0.521

PPARG

Anal Carcinoma

42.852 (6.09, 301.523)

1.601 × 10− 4

3.757 (0.519, 27.180)

0.190

12.909 (3.217, 51.795)

0.0003

 

Cardia Cancer

1.440 (0.29, 7.151)

0.656

11.018 (5.995, 202.492)

0.109

3.851 (0.525, 28.257)

0.185

 

Gastric Cancer

0.063 (0.012, 0.339)

0.001

0.758 (0.545, 1.055)

0.101

0.691 (0.500, 0.956)

0.026

 

Hepatocellular Carcinoma

63.807 (13.260, 306.900)

2.152 × 10− 7

3.644 (0.150, 88.367)

0.026

36.507 (8.929, 149.259)

< 0.0001

 

Intrahepatic Cholangiocarcinoma

8.980 (1.241, 64.975)

0.030

5.238 (2.699, 12.193)

0.046

5.609 (2.772, 11.347)

< 0.0001

 

Pancreatic Cancer

0.290 (0.171, 0.492)

4.549 × 10− 6

0.010 (0.004, 0.023)

2.371 × 10− 27

0.110 (0.071, 0.172)

< 0.0001

 

Rectum Cancer

2.031 (0.616, 6.690)

0.244

1.470 (0.974, 22.190)

0.066

1.803 (0.699, 4.654)

0.223

PRKAB1

Anal Carcinoma

0.035 (4.917 × 10− 4, 2.539)

0.125

0.608 (7.671 × 10− 6, 482.378)

0.090

0.059 (0.001, 2.814)

0.151

 

Cardia Cancer

20.741 (0.854, 503.700)

0.062

3.209 (0.805, 1.279 × 103)

0.098

9.325 (0.836, 104.023)

0.070

 

Gastric Cancer

0.285 (0.007, 11.250)

0.503

1.032 (0.551, 1.933)

0.922

0.995 (0.536, 1.847)

0.987

 

Hepatocellular Carcinoma

0.097 (0.003, 3.010)

0.183

6.206 (0.541, 71.205)

0.143

1.541 (0.211, 11.276)

0.670

 

Intrahepatic Cholangiocarcinoma

544.800 (7.099, 4.18 × 104)

4.441 × 10− 3

11.327 (0.369, 477.766)

0.067

54.449 (3.434, 863.226)

0.005

 

Pancreatic Cancer

0.599 (0.133, 2.703)

0.505

0.157 (0.025, 0.975)

0.069

0.348 (0.109, 1.114)

0.075

 

Rectum Cancer

2.403 (0.757, 7.626)

0.137

3.529 (0.110, 112.742)

0.333

2.497 (0.835, 7.470)

0.102

SLC5A2

Anal Carcinoma

0.153 (0.004, 6.058)

0.317

0.370 (0.009, 15.078)

0.599

0.237 (0.017, 3.230)

0.280

 

Cardia Cancer

43.268 (2.771, 675.700)

0.007

11.038 (3.381, 36.036)

6.951 × 10− 5

13.666 (4.610, 40.515)

< 0.0001

 

Gastric Cancer

0.652 (0.016, 26.550)

0.821

29.569 (11.585, 551.493)

0.065

6.183 (0.156, 244.359)

0.332

 

Hepatocellular Carcinoma

100.541 (2.926, 3.455 × 103)

0.011

22.507 (4.289, 118.097)

0.092

29.465 (6.568, 132.195)

< 0.0001

 

Intrahepatic Cholangiocarcinoma

46.219 (0.439, 4.868 × 103)

0.107

1.165 (0.400, 3.393)

0.780

1.401 (0.494, 3.971)

0.527

 

Pancreatic Cancer

6.650 (2.529, 17.486)

1.227 × 10− 4

15.351 (2.686, 87.744)

0.002

8.096 (3.476, 18.857)

< 0.0001

 

Rectum Cancer

1.284 (0.432, 3.814)

0.652

1.109 (0.525, 2.341)

0.786

1.162 (0.628, 2.152)

0.633